BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28988435)

  • 1. Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children.
    Macken M; Dale H; Moyo D; Chakmata E; Depani S; Israels T; Niyrenda D; Bailey S; Chagaluka G; Molyneux EM
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin.
    Chagaluka G; Stanley C; Banda K; Depani S; Nijram'madzi J; Katangwe T; Israels T; Bailey S; Mukaka M; Molyneux E
    Eur J Cancer; 2014 May; 50(8):1472-81. PubMed ID: 24636877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
    Krown SE; Moser CB; MacPhail P; Matining RM; Godfrey C; Caruso SR; Hosseinipour MC; Samaneka W; Nyirenda M; Busakhala NW; Okuku FM; Kosgei J; Hoagland B; Mwelase N; Oliver VO; Burger H; Mngqibisa R; Nokta M; Campbell TB; Borok MZ;
    Lancet; 2020 Apr; 395(10231):1195-1207. PubMed ID: 32145827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
    Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
    J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study.
    El-Mallawany NK; Kamiyango W; Slone JS; Villiera J; Kovarik CL; Cox CM; Dittmer DP; Ahmed S; Schutze GE; Scheurer ME; Kazembe PN; Mehta PS
    PLoS One; 2016; 11(4):e0153335. PubMed ID: 27082863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME; Lachter J; Spencer D; Bezwoda WR
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea.
    Bekolo CE; Soumah MM; Tiemtore OW; Diallo A; Yuma JD; Di Stefano L; Metcalf C; Cisse M
    BMC Cancer; 2017 Dec; 17(1):806. PubMed ID: 29197357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi sarcoma in HIV-seronegative children presenting to the paediatric oncology ward in The Queen Elizabeth Central Hospital, Blantyre, Malawi during 2002-2014.
    Mittermayer-Vassallo K; Banda K; Molyneux EM
    Trop Doct; 2016 Jul; 46(3):138-42. PubMed ID: 26620689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.
    Zhong DT; Shi CM; Chen Q; Huang JZ; Liang JG; Lin D
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):425-30. PubMed ID: 22160130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes of AIDS-associated Kaposi's sarcoma under a routine antiretroviral therapy program in Lilongwe, Malawi: bleomycin/vincristine compared to vincristine monotherapy.
    Mwafongo AA; Rosenberg NE; Ng'ambi W; Werner AB; Garneau WM; Gumulira J; Phiri S; Hosseinipour MC
    PLoS One; 2014; 9(3):e91020. PubMed ID: 24632813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi sarcoma in South African children.
    Stefan DC; Stones DK; Wainwright L; Newton R
    Pediatr Blood Cancer; 2011 Mar; 56(3):392-6. PubMed ID: 21225916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.
    Mosam A; Shaik F; Uldrick TS; Esterhuizen T; Friedland GH; Scadden DT; Aboobaker J; Coovadia HM
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):150-7. PubMed ID: 22395672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries.
    Bacha JM; El-Mallawany NK; Slone JS; Wilkinson JP; Mehta PS; Campbell LR
    Int J STD AIDS; 2020 Jul; 31(8):724-734. PubMed ID: 32493141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
    Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
    BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis.
    Freeman EE; McCann NC; Semeere A; Reddy KP; Laker-Oketta M; Byakwaga H; Pei PP; Hajny Fernandez ME; Kiprono S; Busakhala N; Martin JN; Maurer T; Bassett IV; Freedberg KA; Hyle EP
    Lancet Glob Health; 2022 Aug; 10(8):e1179-e1188. PubMed ID: 35839816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Kaposi sarcoma in children with HIV-1 infection.
    Anglemyer A; Agrawal AK; Rutherford GW
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
    Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
    Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose multidrug chemotherapy plus Pneumocystis carinii pneumonia prophylaxis for HIV-related Kaposi's sarcoma.
    Shields PG; Dawkins F; Holmlund J; Cohen P; Schulof RS
    J Acquir Immune Defic Syndr (1988); 1990; 3(7):695-700. PubMed ID: 1693677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma.
    Plettenberg A; van Dyk U; Stoehr A; Albrecht H; Stellbrink HJ; Berger J; Meigel W
    Dermatology; 1997; 194(3):234-7. PubMed ID: 9187839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana.
    Cox CM; El-Mallawany NK; Kabue M; Kovarik C; Schutze GE; Kazembe PN; Mehta PS
    Pediatr Blood Cancer; 2013 Aug; 60(8):1274-80. PubMed ID: 23487320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.